Opko Health

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging our discovery, development, and commercialization expertise and our novel and proprietary technologies. We intend to leverage our global commercialization expertise to pursue acquisitions of commercial businesses that will both drive our growth and provide geographically diverse sales and distribution opportunities. We have and may continue to make investments in other early stage companies that we perceive to have valuable proprietary technology and significant potential to create value for OPKO as a shareholder. Our Focus is on Point-of-Care and Novel Molecular Diagnostics, Proprietary Pharmaceuticals, and Vaccines. Since 2009, OPKO has completed five national and international acquisitions contributing to its technology and commercial operations. OPKO continues to explore acquisition opportunities for complementary pharmaceuticals, compounds, technologies, and businesses. We expect our future growth to arise from leveraging our proprietary technology, development strengths, and pursuit of complementary and strategic acquisitions and investments.
Miami, US
5,936 (est)

Key People at Opko Health

Jane H. Hsiao

Jane H. Hsiao

Phillip Frost

Phillip Frost


Opko Health Locations

Miami, US
Woburn, US

Opko Health Metrics

Opko Health Summary

Founding Date


Market capitalization

$5.18 B

Closing share price


Opko Health Market Value History

Opko Health News

Opko Health Company Life